Valence 로고
인기
로그인
Loading data for OGN — first visit, this takes a few seconds.

관심목록에 추가

Organon & Co.

NYSE: OGN · 실시간 가격 · USD
13.70
-0.02 (-0.15%)
종가 기준: Aug 19, 2026, 7:53 PM

Organon & Co. (OGN) Stock Price, Analysis & Data

-0.15%

데이터 없음

매수호가n/a
시가총액3.61B
매출 (ttm)6.13B
순이익 (ttm)209M
베타1.52
EPS (ttm)0.78
P/E (ttm)17.61
선행 P/E3.78
P/B (ttm)3.59
P/S (ttm)0.59
Earnings DateNov 9, 2026
매도호가n/a
거래량1,702,121
평균 거래량 (20일)2,615,227
시가13.71
전일 종가13.72
일중 범위13.69 - 13.72
52주 범위5.69 - 13.72
애널리스트n/a
목표주가n/a
배당$0.08 (0.58%)
배당락일2026년 8월 14일

OGN 소개

Organon & Co. develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally. The company's women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; C...

[더 보기]
산업 Drug Manufacturers - General
섹터 Healthcare
IPO 일자 May 14, 2021
직원 수 10,000
상장 거래소 NYSE
티커 OGN
웹사이트 https://www.organon.com
전체 기업 정보

재무 실적

2025년 Organon &의 매출은 6.22B로, 전년 6.4B 대비 -2.92% 감소했습니다. 순이익은 187M로, -78.36% 감소했습니다.

재무제표

어닝 서프라이즈

Organon &가 Jul 31, 2026에 분기 실적을 발표했습니다:
  • 매출 $1.56B 예상치 하회 $0, 및 -2.26% 전년 대비 감소.
  • EPS 0.85 예상치 하회 -0.22, 및 -15.00% 전년 대비 감소.

    • 다음 실적 발표

    Organon & Co.의 실적 발표 예정일은 Nov 9, 2026, 장 시작 전입니다.
    애널리스트 예상 매출은 ... 업그레이드
    news image

    2주 전 · Zacks

    Compared to Estimates, Organon (OGN) Q2 Earnings: A Look at Key Metrics

    Although the revenue and EPS for Organon (OGN) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street es...

    news image

    2주 전 · Zacks

    Organon (OGN) Lags Q2 Earnings Estimates

    Organon (OGN) delivered earnings and revenue surprises of -2.30% and +1.09%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

    news image

    2주 전 · Reuters

    Sun Pharma's quarterly profit jumps on strength in specialty medicines

    By Kashish Tandon July 31 (Reuters) - India's Sun Pharmaceutical Industries reported a 27% rise in first-quarter profit on Friday, driven by robust growth in its high-margin specialty medicines

    news image

    3주 전 · Zacks

    Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know

    Organon (OGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

    news image

    3주 전 · MarketBeat

    Organon & Co. Shareholders Clear Sun Pharma Merger Deal

    Shareholders of Organon & Co. (NYSE:OGN) approved the company’s proposed merger agreement with Sun Pharmaceutical Holdings USA, Inc. at a virtual special meeting held Wednesday, according to prelimina...

    2 페이지 중 1